Pharmacological relaxation of the ureter when using access sheaths during endoscopy of the kidney
- Conditions
- Resistance in the ureter when inserting a ureteral access sheath during ureterorenoscopy.MedDRA version: 16.1Level: LLTClassification code 10023436Term: Kidney stoneSystem Organ Class: 100000004857Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]
- Registration Number
- EUCTR2013-004475-13-DK
- Lead Sponsor
- Fredericia Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 22
Indication for diagnostic og therapeutic flexible ureterorenoscopy, and expected use of access sheath.
Age > 18 years.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 7
Allergy to isoprenalin
JJ-catheter in situ
Nephrostomy in situ
Ipsilateral ureteral stone
Known malignancies in bladder, ureter or kidney
Pregnancy
Lactation
Disempowered
In custody
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To investigate if addition of isoprenaline to the irrigation fluid makes it possible to insert an access sheath in the ureter of patients were insertion was impossible because of ureteral resistance.;Secondary Objective: Assessment of peroperative lesions in the ureter.<br>Assessment of postoperative complications.;Primary end point(s): If addition of isoprenaline to the irrigation fluid makes it possible to fully insert a ureteral access sheath to the kidney in patients where this was not possible because of ureteral resistance.;Timepoint(s) of evaluation of this end point: After 1 minute of irrigation, insertion of ureteral access sheath wil be attempted. If it is not possible irrigation is repeated for 1 minute before another attempt of insertion. This is repeated max. 5 times, where after the intervention is over.<br>If insertion is successfull the intervention is over as well.
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Assessment of peroperative lesions in the ureter.<br>Assessment of postoperative complications, infection or bleeding.;Timepoint(s) of evaluation of this end point: During the operation and until discharge from the hospital.